Randall Kaye's Net Worth
$2.32 Million
Who is Randall Kaye?
Randall Kaye has an estimated net worth of $2.32 Million. This is based on reported shares across multiple companies, which include Axsome Therapeutics, Inc., Longboard Pharmaceuticals, Inc., and AVANIR PHARMACEUTICALS.
SEC CIK
Randall Kaye's CIK is 0001350416
Past Insider Trading and Trends
2008 was Randall Kaye's most active year for acquiring shares with 3 total transactions. Randall Kaye's most active month to acquire stocks was the month of November. 2010 was Randall Kaye's most active year for disposing of shares, totalling 12 transactions. Randall Kaye's most active month to dispose stocks was the month of July. 2024 saw Randall Kaye paying a total of $72,501.45 for 142,147 shares, this is the most they've acquired in one year. In 2024 Randall Kaye cashed out on 33,334 shares for a total of $578,804.39, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Axsome Therapeutics, Inc. (AXSM) Snapshot price: $93.185
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +19.91% | 1K |
$9.03 | $9,026.00 | 6.02K |
Dec 23
| |||
Form 4
|
∞
| 5.02K |
$5.40 | $27,118.80 | 5.02K |
Nov 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Longboard Pharmaceuticals, Inc. (LBPH) Snapshot price: $34.86
CMO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 25
| |||
Form 4
|
—
|
0
|
$31.70 | -$911,434.89 | 17.92K |
Oct 15
| |||
Form 4
|
—
|
0
|
$18.00 | -$454,821.07 | 17.92K |
Sep 16
| |||
Form 4
|
—
|
0
|
$21.20 | -$505,907.94 | 17.92K |
Jan 23 - Aug 12
| |||
Form 4
|
∞
| 17.92K |
—
|
—
| 17.92K |
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVANIR PHARMACEUTICALS No price found
Sr. VP, Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -60.35% | -100.00K |
$2.75 | -$275,000.00 | 65.69K |
Scheduled
|
Sep 9
| ||
Form 4
| -5.69% | -10.00K |
$4.05 | -$40,500.00 | 165.69K |
Scheduled
|
Jan 5
| ||
Form 4
| -0.82% | -1.45K |
$3.92 | -$5,668.32 | 175.69K |
Dec 13
| |||
Form 4
| -5.34% | -10.00K |
$3.80 | -$38,000.00 | 177.14K |
Scheduled
|
Dec 6
| ||
Form 4
| +9.76% | 17.5K |
—
|
—
| 196.84K |
Dec 1
| |||
Form 4
| -5.07% | -10.00K |
$4.76 | -$47,556.00 | 187.14K |
Scheduled
|
Nov 5
| ||
Form 4
| -4.22% | -10.00K |
$3.23 | -$32,269.00 | 227.04K |
Scheduled
|
Oct 5
| ||
Form 4
| -0.61% | -1.45K |
$2.70 | -$3,906.90 | 237.04K |
Sep 13
| |||
Form 4
| -4.02% | -10.00K |
$2.70 | -$27,034.00 | 238.48K |
Scheduled
|
Sep 7
| ||
Form 4
| -12.35% | -35.00K |
$3.08 | -$107,663.50 | 248.48K |
Aug 18
| |||
Form 4
| -3.41% | -10.00K |
$3.28 | -$32,800.00 | 283.48K |
Scheduled
|
Aug 5
| ||
Form 4
| -3.30% | -10.00K |
$3.02 | -$30,203.00 | 293.48K |
Scheduled
|
Jul 7
| ||
Form 4
| -0.47% | -1.45K |
$2.71 | -$3,921.37 | 303.48K |
Jun 13
| |||
Form 4
| -14.09% | -50.00K |
$2.38 | -$119,115.00 | 304.93K |
Scheduled
|
Jun 7
| ||
Form 4
| -0.41% | -1.45K |
$2.13 | -$3,084.24 | 354.93K |
Mar 13
| |||
Form 4/A
| -7.07% | -28.08K |
$1.97 | -$55,315.63 | 368.88K |
Jan 4
| |||
Form 4
| -7.18% | -28.50K |
$1.97 | -$56,143.03 | 368.46K |
Jan 4
| |||
Form 4
| -0.34% | -1.35K |
$1.82 | -$2,457.00 | 396.96K |
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 27
| |||
Form 4
| -0.34% | -1.35K |
$2.16 | -$2,821.29 | 398.31K |
Sep 11 - Sep 15
| |||
Form 4
| -5.54% | -23.43K |
$2.13 | -$49,895.25 | 399.66K |
Jul 15
| |||
Form 4
| -0.29% | -1.22K |
$1.31 | -$1,594.27 | 423.08K |
Jun 13
| |||
Form 4
| -0.34% | -1.44K |
$0.45 | -$648.00 | 424.3K |
Mar 13
| |||
Form 4
| +2.41% | 10K |
$0.43 | $4,263.00 | 425.74K |
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
| -0.29% | -1.22K |
$0.83 | -$1,010.11 | 415.74K |
Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31 - Jul 31
| |||
Form 4
| -0.29% | -1.22K |
$1.11 | -$1,350.87 | 416.95K |
Jun 13
| |||
Form 4
| -0.34% | -1.44K |
$1.10 | -$1,584.00 | 418.17K |
Mar 13
| |||
Form 4
| +1.82% | 7.52K |
$0.59 | -$5,130.79 | 419.61K |
May 8 - Jan 17
| |||
Form 4
| -1.23% | -5.15K |
$1.66 | -$8,545.68 | 412.1K |
Dec 13
| |||
Form 4/A
| +34.55% | 107.14K |
—
|
—
| 417.24K |
Dec 4
| |||
Form 4
| +34.55% | 107.14K |
—
|
—
| 417.24K |
Dec 4
| |||
Form 4
| +419.46% | 250K |
—
|
—
| 309.6K |
Mar 21
| |||
Form 4
| +2,880.00% | 57.6K |
—
|
—
| 59.6K |
Dec 13
| |||
Form 4
|
∞
| 2.5K |
$9.98 | $25,229.50 | 2.5K |
May 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||